Virtual reality vs. play cards: a new battle to calm Kids' inhaler fears

NCT ID NCT07780331

Recruiting now Symptom relief Sponsor: Bandırma Onyedi Eylül University Source: ClinicalTrials.gov ↗

This trial is taking on new participants right now.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether virtual reality goggles or gaming cards can help reduce fear, anxiety, and stress-related changes in heart rate and oxygen levels in children aged 4 to 6 during inhaler treatment. Children receiving inhaler medication often feel scared and anxious, which can affect their cooperation and vital signs. The study compares these two distraction methods against standard care to see which better eases the experience.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Virtual reality goggles (VR BOX) and gaming cards used as distraction tools during inhaler medication
What this could lead to: If effective, these distraction methods could offer a simple, drug-free way to reduce fear and anxiety in young children during inhaler treatments, potentially improving their cooperation and vital signs.
What could go wrong: This is a relatively small trial in a specific age group, and results may not apply broadly. The effectiveness of distraction can vary widely among children, and the study does not measure long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 6 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Child being between the ages of 4 and 6 years. * Parents and children being completely voluntary to participate in the study. * Child having no visual, auditory, or cognitive communication barriers. * Child's cognitive level and motor development being appropriate for their age. * Child having no life-threatening acute or chronic systemic disease. * Child having no mental or neurological disability or condition. * Child and parent being fully open to effective communication and clinical cooperation. * Child having no medical condition that prevents inhaler mask or nebulizer application. Exclusion Criteria: * Child having any acute clinical condition that mechanically prevents inhaler treatment. * Child having a severe, life-threatening acute or chronic health problem at presentation. * Sudden development of severe clinical instability preventing completion of the trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder respiratory system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY FEAR PEDIATRIC DISORDERS RESPIRATORY TRACT DISEASES

Contacts and locations

Locations

Susurluk State Hospital, Emergency Department
RECRUITING

Balıkesir, Balıkesir, 10600, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.